HTA126 How Did French Health Technology Assessment Body (Transparency Committee, TC, of the HAS) Assess Drugs with Clinical Development Based on Single Arm Trials in the Last Three Years?
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1810
https://www.valueinhealthjournal.com/article/S1098-3015(23)04940-9/fulltext
Title :
HTA126 How Did French Health Technology Assessment Body (Transparency Committee, TC, of the HAS) Assess Drugs with Clinical Development Based on Single Arm Trials in the Last Three Years?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04940-9&doi=10.1016/j.jval.2023.09.1810
First page :
Section Title :
Open access? :
No
Section Order :
11252